A spliced form of CD44 expresses the unique glycan that is recognized by the prostate cancer specific antibody F77

Prostate cancer is the most common cancer occurring in men in the United States. The monoclonal antibody F77 that was originally developed in our laboratory recognizes mainly glycolipids as well as O-linked glycosylation on proteins in prostate cancer cells. We have identified a spliced form of glyc...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Chen, Xi, Nagai, Yasuhiro, Zhu, Zhiqiang, Ruan, Hang, Peehl, Donna M., Greene, Mark I., Zhang, Hongtao
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2017
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5790488/
https://ncbi.nlm.nih.gov/pubmed/29423071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23341
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak